Table 2.

Different management of type 2 diabetes mellitus patients in the study groups.

	Statin		No Statin
	Count	%	Count	%
Insulin
Yes	37	94.9%	2	5.1%
No	26	78.1%	7	21.9%
Metformin
Yes	49	94.2%	3	5.8%
No	14	70.0%	6	30.0%
Gliclazide
Yes	11	84.6%	2	15.4%
No	52	88.1%	7	11.9%
Repaglinide
Yes	6	100.0%	0	0.0%
No	57	86.4%	9	13.6%
Glimepiride
Yes	2	100.0%	0	0.0%
No	61	87.1%	9	12.9%